CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
BERKELEY HEIGHTS, N.J., April 15, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and […]
iPower to Participate in the Water Tower Research Fireside Chat Series on April 18
RANCHO CUCAMONGA, Calif., April 15, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and […]
LiveOne (Nasdaq: LVO) Subsidiary Slacker Radio Hits All Time High Country Music Usage, Helping to Increase Revenue 300% and Driving a Remarkable 800% Increase in Share of Female Country Artists Across Radio Programming
– Management Guides Slacker Radio to $85M and $20M Adjusted EBITA for FY2025; a 4X Revenue Growth and Increase of […]
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
MIAMI, April 15, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today […]
PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement
Fiscal 2024 3Q Revenue of $65.3 million, an 11% increase compared to last year including PetCareRx results.AutoShip & Save and […]
KULR Technology Group Announces Appointment of Donna H. Grier to its Board of Directors
Former DuPont Executive Brings Decades of Private and Public Market Experience to Company’s Board SAN DIEGO, April 15, 2024 (GLOBE […]
Blue World Acquisition Corporation Postponed the Extraordinary General Meeting to Approve the Business Combination with TOYO Solar Pending A Post-Effective Amendment to The Registration Statement
New York, April 15, 2024 (GLOBE NEWSWIRE) — Blue World Acquisition Corporation (“Blue World”) (NASDAQ: BWAQ) today announced that it […]
Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights
– RECOVER-1 Phase 3 global trial successfully met all primary and secondary endpoints with statistically significant reductions across all major […]
ACV Transportation Expands Services to Vehicles Purchased Outside of the ACV Platform
BUFFALO, N.Y., April 15, 2024 (GLOBE NEWSWIRE) — ACV (Nasdaq: ACVA), the leading digital automotive marketplace and data services partner […]
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
SAN DIEGO, April 15, 2024 (GLOBE NEWSWIRE) — Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing […]
